Meloxicam (15 mg) does not interfere with the antiplatelet effect of aspirin in healthy volunteers

被引：0
|
作者：
van Ryn, J
Kink-Eiband, M
Kuritsch, I
Feifel, U
Hanft, G
Wallenstein, G
Trummlitz, G
机构：
[1] Boehringer Ingelheim KG, Drug Discovery Support, Biberach, Germany
[2] Boehringer Ingelheim KG, Clin Res, Biberach, Germany
[3] Boehringer Ingelheim KG, Med Data Serv, Biberach, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [31] A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX®), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers
    Greenberg, HE
    Gottesdiener, K
    Huntington, M
    Wong, P
    Larson, P
    Wildonger, L
    Gillen, L
    Dorval, E
    Waldman, SA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (12): : 1509 - 1515
  • [32] Effect kinetics of desmopressin-induced platelet retention in healthy volunteers treated with aspirin or placebo
    Lethagen, S
    Olofsson, L
    Frick, K
    Berntorp, E
    Björkman, S
    HAEMOPHILIA, 2000, 6 (01) : 15 - 20
  • [33] Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers
    Karha, Juhana
    Rajagopal, Vivek
    Kottke-Marchant, Kandice
    Bhatt, Deepak L.
    AMERICAN HEART JOURNAL, 2006, 151 (05) : 976.e7 - 976.e11
  • [34] Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel
    Leadbeater, P. D. M.
    Kirkby, N. S.
    Thomas, S.
    Dhanji, A. -R.
    Tucker, A. T.
    Milne, G. L.
    Mitchell, J. A.
    Warner, T. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (10) : 2050 - 2056
  • [35] COMPARATIVE ANTIPLATELET AGGREGATION EFFECT OF TWO CLOPIDOGREL PRODUCTS UNDER STEADY STATE CONDITION IN HEALTHY VOLUNTEERS
    Tiamkao, S.
    Nakkam, N.
    Kanjanawart, S.
    Tassaneeyakul, W.
    CEREBROVASCULAR DISEASES, 2014, 37 : 341 - 341
  • [36] Low-dose naproxen interferes with the antiplatelet effect of low-dose aspirin in healthy subjects
    Anzellotti, Paola
    Capone, Marta L.
    Tontodonati, Paola
    Caniglia, Giuseppina
    Petrelli, Maria
    Di Francesco, Luigia
    Tacconelli, Stefania
    Merciaro, Gabriele
    Di Gregorio, Patrizia
    Patrignani, Paola
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E70 - E70
  • [37] Determination of the dose proportionality of single intravenous doses (5, 10, and 15 mg) of lubeluzole in healthy volunteers
    Herron, J
    Lee, P
    Pesco-Koplowitz, L
    Gajjar, D
    Soo, YW
    Woestenborghs, R
    CLINICAL THERAPEUTICS, 1998, 20 (04) : 682 - 690
  • [38] Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease
    Larsen, Sanne Bojet
    Grove, Erik Lerkevang
    Neergaard-Petersen, Sos
    Wurtz, Morten
    Hvas, Anne-Mette
    Kristensen, Steen Dalby
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08):
  • [39] Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions
    Lepäntalo, A
    Virtanen, KS
    Heikkilä, J
    Wartiovaara, U
    Lassila, R
    EUROPEAN HEART JOURNAL, 2004, 25 (06) : 476 - 483
  • [40] Vardenafil does not alter aspirin-induced prolongation of bleeding time in normal healthy volunteers: a phase I study
    Mazzu, A
    Rajagopalan, P
    Xia, CG
    Leese, P
    Sundaresen, P
    PHARMACOTHERAPY, 2003, 23 (03): : 399 - 400
12345